Accordingly, low EpCAM expression was observed in melanoma, some neurological cancers, lymphomas, and sarcomas [15], while high EpCAM expression was observed in breast [61], gallbladder [105], gastric [106], pancreatic [107], prostate [108,109], and colorectal cancers [110]. The gene discussed is EPCAM; the disease is colorectal cancer.